Epstein–Barr Virus Antibody Titers Are Not Associated with Gastric Cancer Risk in East Asia

Background Epstein–Barr virus (EBV)-positive gastric cancers represent a distinct subtype of gastric cancers and account for nearly 10% of the gastric cancer burden, yet risk detection strategies for this cancer subtype are lacking. Methods We conducted a nested case–control study where we assayed 4...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Digestive diseases and sciences 2018-10, Vol.63 (10), p.2765-2772
Hauptverfasser:	Varga, Matthew G., Cai, Hui, Waterboer, Tim, Murphy, Gwen, Shimazu, Taichi, Taylor, Phil R., Qiao, You-Lin, Park, Sue K., Yoo, Keun-Young, Jee, Sun Ha, Cho, Eo Rin, Kim, Jeongseon, Abnet, Christian C., Tsugane, Shoichiro, Cai, Qiuyin, Zheng, Wei, Pawlita, Michael, Shu, Xiao-Ou, Epplein, Meira
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antigens Biochemistry Cancer Epstein-Barr virus Gastric cancer Gastroenterology Health aspects Health risk assessment Hepatology Medicine Medicine & Public Health Oncology Oncology, Experimental Original Article Risk factors Stomach cancer Transplant Surgery Viral antibodies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!